Richard D. Cummings

From Wikipedia, the free encyclopedia
Jump to: navigation, search

<> <> <>

Richard D. Cummings, PhD, is the William Patterson Timmie Professor and Chairman of the Department of Biochemistry at Emory University School of Medicine in Atlanta, Georgia. He is a co-founder, among many other well-known scientists, of the field of glycomics and glycobiology.

Before moving to Emory University, Cummings was the Ed Miller Endowed Chair in Molecular Biology, the George Lynn Cross Professor in Biochemistry, and Professor of Biochemistry and Molecular Biology at the University of Oklahoma Health Sciences Center, College of Medicine, in Oklahoma City, Oklahoma. At the University of Oklahoma Health Sciences Center, Cummings was a founder of the Oklahoma Center for Medical Glycobiology (founded in 1999). At Emory University Cummings was a co-founder and is currently co-Director of the Glycomics Center at Emory University School of Medicine (founded in 2007).

Cummings is the co-founder, along with Rodger P. McEver, MD, and Richard Alvarez, MBA, of Selexys Pharmaceutical Corporation, where he initially served as President and Chief Scientific Officer. Selexys Pharmaceutical Corporation is based in Oklahoma City, Oklahoma.

Cummings graduated from Isabella High School in Chilton County, AL in 1970, and then received his B.S. in Biology from the University of Montevallo in 1974. He received his Ph.D. in Biochemistry from The Johns Hopkins University in 1980. He was a Postdoctoral Fellow in the Division of Hematology/Oncology at Washington University in St. Louis from 1980 through 1983.